Publications found:
192
Sort by:
Global Insulin Aspart 30 Injection Market Growth 2026-2032
US$ 3,660.00
The global Insulin Aspart 30 Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United States market fo...
September 2026
94 pages
Global Glargine Insulin Pen Market Growth 2026-2032
US$ 3,660.00
The global Glargine Insulin Pen market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United States market for Glarg...
August 2026
100 pages
Global Oral Simeglutide Market Growth 2026-2032
US$ 3,660.00
The global Oral Simeglutide market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Simeglutide was originally introdu...
August 2026
87 pages
Global Oral Semaglutide Market Growth 2026-2032
US$ 3,660.00
The global Oral Semaglutide market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Oral Semaglutide is the first oral...
August 2026
95 pages
Sulfonylureas Market Size, Share and Growth Outlook 2026: By Drug Type (Glyburide, Glipizide, Glimepiride, Others), By Indication, By Dosage Form, By Route of Administration, By End-User, By Distribution Channel, Companies to 2034.
US$ 3,482.00
The global Sulfonylureas Market size is forecast to increase from $12.93 Billion in 2026 to $17.16 Billion in 2034 at a CAGR of 3.6% between 2026 and 2034. The Sulfonylureas market report provides det...
July 2026
190 pages
Incretin-Based Drugs Market - 2025-2033
US$ 3,400.00
Incretin-Based Drugs Market reached US$28.18 billion in 2025 and is expected to reach US$48.63 billion by 2035, growing with a CAGR of 5.60% during the forecast period 2026-2035. The Incretin-Based Dr...
July 2026
46 pages
South Korea Diabetes Drugs Market Report by Drug (Insulins, Oral Anti-diabetic Drugs, Non-Insulin Injectable Drugs, Combination Drugs), Distribution Channel (Online Pharmacies, Hospital Pharmacies, Retail Pharmacies), and Region 2026-2034
US$ 2,999.00
South Korea diabetes drugs market size reached USD 1.90 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 4.90 Billion by 2034, exhibiting a growth rate (CAGR) of 11.31% du...
July 2026
115 pages
South Korea Oral Anti-Diabetic Drug Market Report by Drugs (Biguanides, Alpha-Glucosidase Inhibitors, Dopamine D2 Receptor Agonist, SGLT-2 Inhibitors, DPP-4 Inhibitors, Sulfonylureas, Meglitinides), and Region 2026-2034
US$ 2,999.00
South Korea oral anti-diabetic drug market size reached USD 897.0 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,191.0 Million by 2034, exhibiting a growth rate (CAGR)...
July 2026
121 pages
Global Dual Incretin Agonists Market Size Study and Forecast by Drug (Tirzepatide, Survodutide, and Others), Disease Indication (Type 2 Diabetes, Obesity, MASH/NASH, and Others), Age Group (Pediatric and Adults), Type (Branded and Generics), Route of Administration (Subcutaneous, Oral, and Others), Distribution Channel, Regional Forecasts 2026-2036
US$ 3,750.00
The global dual incretin agonists market, valued at USD 36.51 billion in 2025, is anticipated to reach approximately USD 82.94 billion by 2036, growing at 7.75% CAGR during the forecast period. Dual i...
June 2026
285 pages
India GLP-1 Receptor Agonist Market Size, Share & Trends Analysis Report By Product (Semaglutide, Tirzepatide, Dulaglutide), By Application (Type 2 Diabetes Mellitus, Cardiovascular Risk), By Route Of Administration, By Distribution Channel, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The India GLP-1 receptor agonist market size was valued at USD 150.8 million in 2025 and is projected to grow from USD 240.5 million in 2026 to USD 1,004.9 million by 2033, at a CAGR of 22.7% from 202...
June 2026
150 pages
